Sarah Nickolls

Sarah is a group leader in the Screening Profiling and Mechanistic Biology department at GlaxoSmithKline. After completing her PhD in molecular pharmacology she undertook post-doctoral studies at Neurocrine Biosciences, before joining Pfizer, where she became a research project leader. She has considerable across a number of different therapy areas including pain and neuroscience. Sarah joined GSK in 2016